Whales with a lot of money to spend have taken a noticeably bearish stance on Eli Lilly.
Looking at options history for Eli Lilly LLY we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 30% of the investors opened trades with bullish expectations and 53% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $328,270 and 10, calls, for a total amount of $923,536.
Expected Price Movements
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $760.0 to $1000.0 for Eli Lilly over the recent three months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 415.89 with a total volume of 71.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Eli Lilly's big money trades within a strike price range of $760.0 to $1000.0 over the last 30 days.
Eli Lilly Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LLY | CALL | TRADE | BULLISH | 08/15/25 | $99.65 | $96.4 | $99.55 | $860.00 | $696.8K | 850 | 74 |
| LLY | CALL | SWEEP | BULLISH | 08/15/25 | $99.65 | $96.9 | $99.12 | $860.00 | $258.9K | 850 | 38 |
| LLY | PUT | TRADE | NEUTRAL | 02/28/25 | $6.35 | $5.65 | $6.0 | $865.00 | $240.0K | 438 | 0 |
| LLY | CALL | SWEEP | BEARISH | 08/15/25 | $99.2 | $96.6 | $99.2 | $860.00 | $138.8K | 850 | 38 |
| LLY | CALL | SWEEP | BULLISH | 08/15/25 | $98.7 | $96.5 | $98.7 | $860.00 | $128.3K | 850 | 0 |
About Eli Lilly
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
In light of the recent options history for Eli Lilly, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Current Position of Eli Lilly
- Currently trading with a volume of 16,241, the LLY's price is up by 0.27%, now at $876.01.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 66 days.
Expert Opinions on Eli Lilly
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $1066.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. Click here for access. * Consistent in their evaluation, an analyst from Truist Securities keeps a Buy rating on Eli Lilly with a target price of $1038. * An analyst from Citigroup has decided to maintain their Buy rating on Eli Lilly, which currently sits at a price target of $1190. * An analyst from Wells Fargo persists with their Overweight rating on Eli Lilly, maintaining a target price of $970.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
